TIMOTHY HANN: Open Payments
NPI 1992210884 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220 in 11 payments from 8 companies in 2025. Trend: 2023 $160 · 2024 $133 · 2025 $220
Food & beverage: $220
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $56 |
| Boston Scientific Corporation | 2 | $34 |
| PFIZER INC. | 1 | $30 |
| TOLMAR, INC. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Laborie Medical Technologies Corp. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: XTANDI, GEMTESA, ELIGARD, KEYTRUDA, Advantage System, ORGOVYX, PLUVICTO, Axonics.
Industry payments across FL — which companies pay providers there.
